Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Debt: 2016-2024

Historic Total Debt for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $615.3 million.

  • Collegium Pharmaceutical's Total Debt fell 9.54% to $570.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 38.48%. This contributed to the annual value of $615.3 million for FY2024, which is 51.91% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Total Debt is $615.3 million, which was up 51.91% from $405.0 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Total Debt ranged from a high of $615.3 million in FY2024 and a low of $110.0 million during FY2021.
  • Moreover, its 3-year median value for Total Debt was $560.1 million (2022), whereas its average is $526.8 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Total Debt surged by 1,269.69% in 2020, and later tumbled by 30.15% in 2021.
  • Over the past 5 years, Collegium Pharmaceutical's Total Debt (Yearly) stood at $157.5 million in 2020, then crashed by 30.15% to $110.0 million in 2021, then soared by 409.07% to $560.1 million in 2022, then fell by 27.68% to $405.0 million in 2023, then spiked by 51.91% to $615.3 million in 2024.